Elisabet Stener-Victorin is an expert in Endocrinology at Karolinska Institute (Sweden). As of October 2026, ScienceLeadR ranks Elisabet Stener-Victorin in the top 1% of experts worldwide for Adnexal Diseases and Gonadal Disorders. Elisabet Stener-Victorin has authored 233 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 1 of them ongoing. SLR score: 890 (community average: 125). How the SLR is computed.

LeadR Profile

Elisabet Stener-Victorin Karolinska Institute Sweden
890 ScienceLeadR Reputation 890
Network Map

Endocrinology

Subspecialties: Biochemistry - Gynecology - Obstetrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

Karolinska Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 233

Citations

Citations: 18 974 1st author: 28 Last author: 78 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Swedish matched-cohort on the association between maternal polyendocrine metabolic ovarian syndrome and next-generation cancer-risk.
PMID 42832302 — ovary, neoplasms, sex, child
JNCI Cancer Spectr20260
Hypoadiponectinemia does not enhance anxiety-like behaviour in a lean PCOS-like mouse model.
PMID 42693220 — depression, quality of life, serum, androgens, adiponectin, hyperandrogenism, mental health
Sci Rep20260
Low-frequency electroacupuncture attenuates insulin resistance in a rat model of diet-induced maternal obesity.
PMID 42597035 — cells, anesthesia, corticosterone, fasting, pregnancy, insulin resistance, insulin, blood, electroacupuncture, blood pressure, litter size, diet, malondialdehyde, obesity, triglycerides, placenta, obesity, maternal
Pregnancy (Hoboken)20260
MASLD, diabetes and PMOS across the female life stages.
PMID 42249186 — diabetes mellitus, androgens, ovary, liver, diabetes mellitus, type 2
Diabetologia20260
Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes.
PMID 42249166 — pregnancy, parturition, ovary, obesity, overweight
Nat Rev Endocrinol Top journal20260

Clinical Studies 13

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3 Study Director: 1

By phase:

N/A 8
Phase 3 3
Phase 1 1
Phase 2 1

By status:

Completed 10
Recruiting 2
Unknown 1

By type:

Interventional 11
Observational 2

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 1
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Novel Subtypes of Polycystic Ovary Syndrome
NCT06124391 — ovary, cohort studies, diagnosis, polycystic ovary syndrome
N/ARecruiting2021

LeadR Networks

Main global connection map